Medical Devices

NanoVasc

Brief Description

NanoVasc, Inc. is a medical device company that designs and manufactures biomimetic materials that are non-thrombogenic, durable and demonstrate long-term patency. The Company uses an electrospinning process to manufacture scaffolds in a multitude of shapes and sizes, and then application-specific modifications are applied to the scaffolds surface in order to achieve desired results. These specific modifications are designed to optimize the devices outcome based on its delivery location. The Company's first product is a synthetic vascular graft for hemodialysis access....

CaseForge, Inc.

Brief Description

CaseForge produces personalized stabilizers for use in research and clinical imaging. These stabilizers interface with medical devices to precisely position the patient and eliminate motion, guaranteeing comfortable, fast, simple placement consistency across treatments.

The company was founded by graduate students in the lab of Dr. Jack Gallant, a professor in the UC Berkeley Department of Psychology, and an affiliate in Electrical Engineering and Computer Science, and programs in Neuroscience, Bioengineering, Biophysics and Vision...

Vitruvian Medical Devices

Brief Description

Vitruvian Medical Devices specializes in surgical device innovations and wound care. The company's first product, MYOSEAL, is a sealing spray designed to prevent incisional hernias post operations. The company is working on refining a second product, the Sentinel Bandage - a bandage that senses tissue damage in real-time to prevent the formation of pressure ulcers.

The company has been incubated in the UCSF Catalyst Program, UCSF LaunchPad, QB3 Startup-in-a-Box, and National Science Foundation I-Corps Lean Startup.

Timeline...

Thuris Corporation

Brief Description

Thuris Corporation was a biopharmaceutical company focused on medical device solutions to aid in drug development and diagnosis of central nervous system (CNS) disorders including mild cognitive impairment and Alzheimer's disease. Thuris was also developing pharmaceuticals for select CNS orphan and niche indications ranging from ischemia-related conditions, brain inflammation and Huntington's disease. Thuris received 510k FDA clearance for a non-invasive medical device, the NeuroGraph, for diagnosis of neurological and psychiatric disorders over a broad range of brain-...

Tenaya Therapeutics

Brief Description

Tenaya Therapeutics is shaping the future of heart disease treatment driven by a mission to discover, develop, and deliver curative therapies that address the underlying drivers of heart disease. Tenaya is developing therapies for rare genetic disorders as well as for more prevalent heart conditions through three platforms: Gene Therapy, Cellular Regeneration, and Precision Medicine. The company was founded by leading cardiology researchers at the Gladstone Institutes and UT Southwestern, and backed by a top-tier syndicate of investors.

Timeline 2016...

Synvivia, Inc.

Brief Description

Synvivia is a synthetic biology company that optimizes cell behavior for gene therapy manufacturing, providing a practical solution for genetically encoded biocontainment. The company is building genetically encoded biocontainment technologies that will enable the widespread use of synthetic biology outside of the laboratory.

The company's technology was developed at UC Berkeley with grants from the NSF and DARPA. The work was published in ACS Synthetic Biology and featured as an Editor’s Choice in Science Magazine. Synvivia has exclusive license to the...

ArKal Medical Inc.

Brief Description

ArKal Medical has developed the next generation continuous glucose monitoring system, using its minimally invasive, proprietary and patented MicroTipª technology. The Microtipsª provide painless access to ISF glucose. The ArKal CGM sensor is worn externally on the skin like a patch and measures glucose using classical electrochemical glucose oxidase enzyme-based chemistry. The GlucoPodª CGM system consists of three main components: a disposable sensor patch, a reusable transmitter, and a reusable wireless smart receiver.

Timeline 2004. Company founded...

Organos, Inc.

Brief Description Developer of cardiac micro physiological systems designed to offer three-dimensional (3D) human cardiac tissue models for advanced analysis. The company's data science ecosystem is used to illuminate the effects of compounds on human cardiac tissue, ranging from acute cardiotoxicity and safety pharmacology to chronic studies to predict drug-induced arrhythmia, thereby enabling the health industry to perform safer and cheaper drug development activities. Timeline 2016. Company founded. 2020. Company participated in Berkeley...

OncoRx Pharmaceuticals, Inc.

Brief Description

OncoRx Pharmaceuticals is an early-stage pharmaceutical company discovering and developing targeted therapies that control the progression of invasive malignant cancer. OncoRx has identified and tested drugs that markedly alter the sustained directional mobility, the uncontrolled cell cycle, and t​​he unrestrained growth and proliferation of intrinsically and acquired therapy-resistant tumors. Unlike non-aggressive primary tumors, the growth, progression and invasiveness of therapy-resistant tumors are not effectively controlled with currently available cancer therapies...

Oncobionic

Brief Description

Oncobionic commercialized irreversible electroporation (IRE) technology, a minimally invasive treatment for tumors that revolutionized cancer therapy. The minimally invasive surgical system delivers 1,500 volts of electric current through needle-like probes, ablating the targeted area, making it possible to remove unresectable tumors near critical structures and major blood vessels without cuts or incisions. IRE exclusively targets the tumor’s cell membranes, leaving critical organs, vasculature, ducts and nerves completely unharmed.

The IRE...